Table 2.
Variant | HSAN1 patients included | MacTel affected/predicted | MacTel unaffected |
---|---|---|---|
SPTLC1 C133Y | 8 | 8 | – |
SPTLC1 C133W | 11 | – | 11 |
SPTLC1 V144D | 1 | – | 1 |
SPTLC2 A182P | 2 | – | 2 |
SPTLC2 N177H | 1 | – | 1 |
SPTLC2 S384F | 2 | 1 | 1 |
TOTAL | 25 | 9 | 16 |
Variant | HSAN1 patients included | MacTel affected/predicted | MacTel unaffected |
---|---|---|---|
SPTLC1 C133Y | 8 | 8 | – |
SPTLC1 C133W | 11 | – | 11 |
SPTLC1 V144D | 1 | – | 1 |
SPTLC2 A182P | 2 | – | 2 |
SPTLC2 N177H | 1 | – | 1 |
SPTLC2 S384F | 2 | 1 | 1 |
TOTAL | 25 | 9 | 16 |